Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
-
19881
(A) Sketch of the cortical column model.
Published 2025“…(D) One feedback-driven condition (i.e., with excitatory input to L5 pyramidal cells). At 700ms an input of 150pA is injected to 25% of pyramidal cells and 5% of PV cells in L5, and excitatory neurons in all other layers decrease their activity while interneurons in layer 6 increase their firing.…”
-
19882
Hh signaling activation by dnPKA-GFP decreases p53 target <i>cyclinG1</i> expression and suppresses apoptosis in <i>shh</i><sup>−/−</sup> mutant embryos.
Published 2010“…All of EGFP-injected embryos had “low” expression of <i>patched1</i>, 25,3 +/− 1,15% (Mean +/− standard deviation) of them had “high” expression of <i>cyclinG1</i> and 24,7 +/− 1,53% had “high” apoptosis levels. dnPKA-GFP mRNA injection led to “high” expression of <i>patched1</i> in 87,7 +/− 3,8% of embryos and decreased expression of <i>cyclinG1</i> and apoptosis levels: “high” proportions are 6 +/− 2% and 5,8 +/− 2,4%, respectively. …”
-
19883
-
19884
-
19885
-
19886
MIA pathway is required for liver and pancreas development.
Published 2018“…(B) Whole mount <i>in situ</i> hybridization demonstrates a decreased expression of <i>rbp2b</i> and the liver marker <i>ceruloplasmin</i> (<i>cp</i>), in the liver of <i>mia40a</i> larvae at 5 dpf. n: number of analysed individuals. …”
-
19887
Effect of BoNT/B and TeTx on VAMP2 Immunofluorescence
Published 2013“…In contrast, when cells were first allowed to arrive at the intra-acrosomal Ca<sup>2+</sup>-sensitive step and then treated with toxins, BoNT/B caused a significant decrease of the VAMP2 label (asterisks, [J]), whereas TeTx had no effect (S). …”
-
19888
-
19889
Synthesis, Structure, and Dynamic Behavior of Cyclopentadienyl-Lithium, -Sodium, and -Potassium Annelated with Bicyclo[2.2.2]octene Units: A Systematic Study on Site Exchange of A...
Published 2003“…These values should be compensated for by a decrease in the solvation energies for the metal ions with increasing size, as exemplified by the calculated solvation energy for M<sup>+</sup>(Me<sub>2</sub>O)<sub>4</sub>, which serves as a model for metal ions solvated with four molecules of THF (−122.9 kcal mol<sup>-1</sup> for M = Li; −94.7 kcal mol<sup>-1</sup> for M = Na; −67.7 kcal mol<sup>-1</sup> for M = K). …”
-
19890
Synthesis, Structure, and Dynamic Behavior of Cyclopentadienyl-Lithium, -Sodium, and -Potassium Annelated with Bicyclo[2.2.2]octene Units: A Systematic Study on Site Exchange of A...
Published 2003“…These values should be compensated for by a decrease in the solvation energies for the metal ions with increasing size, as exemplified by the calculated solvation energy for M<sup>+</sup>(Me<sub>2</sub>O)<sub>4</sub>, which serves as a model for metal ions solvated with four molecules of THF (−122.9 kcal mol<sup>-1</sup> for M = Li; −94.7 kcal mol<sup>-1</sup> for M = Na; −67.7 kcal mol<sup>-1</sup> for M = K). …”
-
19891
Synthesis, Structure, and Dynamic Behavior of Cyclopentadienyl-Lithium, -Sodium, and -Potassium Annelated with Bicyclo[2.2.2]octene Units: A Systematic Study on Site Exchange of A...
Published 2003“…These values should be compensated for by a decrease in the solvation energies for the metal ions with increasing size, as exemplified by the calculated solvation energy for M<sup>+</sup>(Me<sub>2</sub>O)<sub>4</sub>, which serves as a model for metal ions solvated with four molecules of THF (−122.9 kcal mol<sup>-1</sup> for M = Li; −94.7 kcal mol<sup>-1</sup> for M = Na; −67.7 kcal mol<sup>-1</sup> for M = K). …”
-
19892
Synthesis, Structure, and Dynamic Behavior of Cyclopentadienyl-Lithium, -Sodium, and -Potassium Annelated with Bicyclo[2.2.2]octene Units: A Systematic Study on Site Exchange of A...
Published 2003“…These values should be compensated for by a decrease in the solvation energies for the metal ions with increasing size, as exemplified by the calculated solvation energy for M<sup>+</sup>(Me<sub>2</sub>O)<sub>4</sub>, which serves as a model for metal ions solvated with four molecules of THF (−122.9 kcal mol<sup>-1</sup> for M = Li; −94.7 kcal mol<sup>-1</sup> for M = Na; −67.7 kcal mol<sup>-1</sup> for M = K). …”
-
19893
Hem25 is required for the effective import of glycine into mitochondria.
Published 2016“…<p>A) Glycine can serve as the sole nitrogen source in <i>S</i>. …”
-
19894
-
19895
-
19896
BIX-01294 attenuates H3K9 methylation and derepresses transcriptional regulation of target genes.
Published 2017“…<p>(A) Western blots showing decrease in H3K9me1 (MCF-7) and H3K9me2 levels (MCF-7 and HeLa) after 48 and 24 hours respectively in the indicated treatments. …”
-
19897
Dyrk1B protein expression and turn-over in Neuro 2a cells.
Published 2013“…Dyrk1B is not detectable in non-transfected Neuro 2a cells (CTL) with available antibody, while transgene Dyrk1B, obvious at 16h, is decreased overtime in a proteasome-specific manner (upper panel). …”
-
19898
-
19899
-
19900
Table_2_Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case...
Published 2023“…Moreover, CADM may necessitate earlier and more aggressive treatment strategies than CDM. Anti-MDA5 antibodies occur at a high level in patients with CADM, not only affecting the symptoms and prognosis of DM but also having a non-negligible impact on the differences between CADM and CDM. …”